US FDA Grants Expanded Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Innovations in Science

We're accelerating the delivery of treatments and cures.

Grants at a Glance

MDA’s research program awards grants to the world’s best scientists investigating promising theories and therapies that may accelerate treatments and cures for families living with muscular dystrophy, ALS and related neuromuscular diseases.

Learn more about the research projects MDA is currently funding:

Research Across Diseases

As part of MDA's basic research program, the grants we fund focus on advancing basic science and generating ideas for potential drug therapies through projects initiated by the researchers themselves. Through the projects they fund we will learn more about the processes that drive neuromuscular diseases. We’ll identify, validate and optimize biological targets at which to aim future therapies. We’ll test potential therapeutic strategies, develop drug development tools and make other advances that will help pave the way to more clinical trials.

Twice a year, grant applications are reviewed by MDA’s Research Advisory Committee which recommends the best projects for approval. Funding is approved by MDA’s Board of Directors.

Find MDA
in your Community